Experiments revealed that the MEK inhibitors not only downregulated the level of ERK phosphorylation but also reduced the apoptotic rate of CDDP-treated NCCIT cells, as previously reported for the cervical carcinoma cell line HeLa (Wang et al, 2000). This evidence concerns the gene MAPK1 and cervical carcinoma.